| Outcome Measures: |
Primary: Descriptive summary of specialty of prescribing physician, Retrospective data analysis from 2022 to 2024|Date of finerenone initiation, Retrospective data analysis from 2022 to 2024|If patient was receiving finerenone at the time of each follow-up visit (Yes/No), Retrospective data analysis from 2022 to 2024|Date of discontinuation of finerenone, Retrospective data analysis from 2022 to 2024|Reason for discontinuation of finerenone, Retrospective data analysis from 2022 to 2024|Dose of finerenone treatment, Retrospective data analysis from 2022 to 2024|Frequency of finerenone treatment, Retrospective data analysis from 2022 to 2024|The number of patients who initiated finerenone with a 10-mg dose and 20-mg dose, Retrospective data analysis from 2022 to 2024|The proportion of patients who initiated finerenone with a 10-mg dose and have up-titrated to a 20-mg dose, Retrospective data analysis from 2022 to 2024|The proportion of patients who initiated finerenone with a 20-mg dose and have down-titrated to a 10-mg dose, Retrospective data analysis from 2022 to 2024|Actions taken after finerenone introduction, Actions include continue treatment, addition of second therapy like SGLT2is, potassium binders, discontinue treatment, Retrospective data analysis from 2022 to 2024|Actions taken after stop finerenone prescription, Actions include initiate alternate therapy like Sodium-glucose transport protein-2 inhibitor (SGLT2is), RAASis or potassium binders, other, Retrospective data analysis from 2022 to 2024 | Secondary: UACR (mg/g) before and after initiating finerenone, UACR: Urine Albumin to Creatinine Ratio, Retrospective data analysis from Aug 2022 to Apr 2024|eGFR before and after initiating finerenone, eGFR: Estimated glomerular filtration rate, Retrospective data analysis from Aug 2022 to Apr 2024|Serum potassium (mmol/L) before and after initiating finerenone, Retrospective data analysis from Aug 2022 to Apr 2024|Change in UACR after initiating finerenone vs month 1, month 4 and end of study, Retrospective data analysis from 2022 to 2024|Change in serum potassium after initiating finerenone vs month 1, month 4 and end of study, Retrospective data analysis from Aug 2022 to Apr 2024|Change in Serum creatinine/eGFR after initiating finerenone vs month 1, month 4 and end of study, Retrospective data analysis from Aug 2022 to Apr 2024|Frequency of events like hospitalization and dialysis due to hyperkalemia, Retrospective data analysis from Aug 2022 to Apr 2024
|
